Supplementary Table 1 from RNA-seq Reveals Aurora Kinase–Driven mTOR Pathway Activation in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma
Sumanta K. Pal(City of Hope), Jeremy O. Jones(City of Hope), Sabina Signoretti(Brigham and Women's Hospital), Toni K. Choueiri(Dana-Farber Cancer Institute), Tommy Tong, Charles Warden(City Of Hope National Medical Center), José A. Karam(The University of Texas MD Anderson Cancer Center), Jinhui Wang(Wenzhou Medical University), Xueli Liu(City of Hope), Clayton Lau(City of Hope), Xiwei Wu(City Of Hope National Medical Center), Miaoling He, Huiqing Wu
Cited by 0
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k